Physician profile
Justin Penticuff
NPI 1134515083
$5,575.25
in general payments reported to CMS, 2019-2025
46 companies · $1,075 in 2025
The $1,075 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $1,163 · 2023: $1,709 · 2024: $1,248 · 2025: $1,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,030.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $698.97 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $650.09 | 2022-2024 | Axonics |
| Boston Scientific Corporation | $604.06 | 2021-2025 | Lithovue, Spaceoar Vue System - 10ml, Axonics |
| Sumitomo Pharma America, INC. | $540.94 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $301.32 | 2021-2023 | Xiaflex |
| Pfizer INC. | $241.99 | 2023-2025 | |
| Teleflex LLC | $222.08 | 2022-2025 | Barrigel, Urolift |
| Convatec INC. | $168.82 | 2022 | |
| Urogen Pharma, INC. | $145.01 | 2023-2025 | Jelmyto |
| Abbvie INC. | $139.97 | 2022-2025 | |
| Urovant Sciences INC | $138.27 | 2022 | |
| Endo USA, INC. | $119.98 | 2024-2025 | Xiaflex |
| Hollister Incorporated | $118.40 | 2022-2023 | Onli, Infyna Chic, Vapro |
| Tolmar, INC. | $115.48 | 2024-2025 | Eligard |
| Olympus America INC. | $110.27 | 2024-2025 | Itind System |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Penticuff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.